FGF21 and obesity due to melanocortin 4 receptor deficiency: Studies indicate that circulating levels of FGF21 are elevated in several metabolic diseases, such as obesity, type 2 diabetes, and fatty liver disease (Zhang et al., 2008; Liu et al., 2015).